Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246293.RAd1JRmsqyUaGZ0ZKbL5MW4Bt2czmGe_lG2oTihREXZno130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246293.RAd1JRmsqyUaGZ0ZKbL5MW4Bt2czmGe_lG2oTihREXZno130_assertion type Assertion NP1246293.RAd1JRmsqyUaGZ0ZKbL5MW4Bt2czmGe_lG2oTihREXZno130_head.
- NP1246293.RAd1JRmsqyUaGZ0ZKbL5MW4Bt2czmGe_lG2oTihREXZno130_assertion description "[The triple-negative breast cancer (TNBC) patients showed a significantly reduced risk of ALN involvement at the time of diagnosis compared to patients with HR-positive/HER2-negative tumors (OR 0.55; 95 % CI 0.49-0.62; P < 0.0001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246293.RAd1JRmsqyUaGZ0ZKbL5MW4Bt2czmGe_lG2oTihREXZno130_provenance.
- NP1246293.RAd1JRmsqyUaGZ0ZKbL5MW4Bt2czmGe_lG2oTihREXZno130_assertion evidence source_evidence_literature NP1246293.RAd1JRmsqyUaGZ0ZKbL5MW4Bt2czmGe_lG2oTihREXZno130_provenance.
- NP1246293.RAd1JRmsqyUaGZ0ZKbL5MW4Bt2czmGe_lG2oTihREXZno130_assertion SIO_000772 25488719 NP1246293.RAd1JRmsqyUaGZ0ZKbL5MW4Bt2czmGe_lG2oTihREXZno130_provenance.
- NP1246293.RAd1JRmsqyUaGZ0ZKbL5MW4Bt2czmGe_lG2oTihREXZno130_assertion wasDerivedFrom befree-2016 NP1246293.RAd1JRmsqyUaGZ0ZKbL5MW4Bt2czmGe_lG2oTihREXZno130_provenance.
- NP1246293.RAd1JRmsqyUaGZ0ZKbL5MW4Bt2czmGe_lG2oTihREXZno130_assertion wasGeneratedBy ECO_0000203 NP1246293.RAd1JRmsqyUaGZ0ZKbL5MW4Bt2czmGe_lG2oTihREXZno130_provenance.